BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership
Business Wire India Total global revenues of $1.5 billion and $5.3 billion for the fourth quarter and full year, increases…